The objective of this application is to obtain funds to open and maintain an animal facility for members of the Cancer Center. Such a facility is needed because infectious agents, and rodent viruses in particular, affect immune functions and animal survival in an uncontrollable manner; natural killer (NK) activity, macrophage functions, tumor resistance, and other immune responses in vivo can be drastically altered by infectious agents. Equally important is the fact that the establishment, growth, and function of T-cell lines in vitro can be drastically altered when """"""""filler cells"""""""" come from mice that have various subclinical infections. Furthermore, experiments testing (or depending upon) latency of virus infections can be seriously affected by intercurrent infections with other viruses. Finally, nude mice are essential for cancer research and must be bred and maintained in an environment that is free of pathogens. The plan is for a double-corridor animal facility with nine animal rooms containing a total of 28 """"""""Illinois cubicles."""""""" The design is based on the experience of other facilities. Because successful operation will depend entirely on very careful and knowledgeable supervision, the facility will be under the direction of a specially trained supervisor who has experience with the biology of rodent viruses and other important murine pathogens. The supervisor in consultations with the veterinarian, will oversee the microbiological testing and will strictly enforce and examine the effectiveness of the guidelines and procedures that must be followed by both the animal caretaker and the investigators using the facility. The high quality of the animal facility will increase the quality of the information obtained from animal experimentation. This in turn will (1) prevent many wasted experiments, (2) lead to more efficient use of research funds, and (3) reduce the number of animals that must be used in experiments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014599-14
Application #
3937788
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Hope, C Matthew; Webber, Jemma L; Tokamov, Sherzod A et al. (2018) Tuned polymerization of the transcription factor Yan limits off-DNA sequestration to confer context-specific repression. Elife 7:
Wu, Chengyue; Pineda, Federico; Hormuth 2nd, David A et al. (2018) Quantitative analysis of vascular properties derived from ultrafast DCE-MRI to discriminate malignant and benign breast tumors. Magn Reson Med :
Wong, Gabrielle S; Zhou, Jin; Liu, Jie Bin et al. (2018) Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nat Med 24:968-977
Ni, Kaiyuan; Lan, Guangxu; Chan, Christina et al. (2018) Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy. Nat Commun 9:2351
Meisel, Marlies; Hinterleitner, Reinhard; Pacis, Alain et al. (2018) Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557:580-584
Webber, Jemma L; Zhang, Jie; Massey, Alex et al. (2018) Collaborative repressive action of the antagonistic ETS transcription factors Pointed and Yan fine-tunes gene expression to confer robustness in Drosophila. Development 145:
Wei, Jiangbo; Liu, Fange; Lu, Zhike et al. (2018) Differential m6A, m6Am, and m1A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm. Mol Cell 71:973-985.e5
Boisclair Lachance, Jean-François; Webber, Jemma L; Hong, Lu et al. (2018) Cooperative recruitment of Yan via a high-affinity ETS supersite organizes repression to confer specificity and robustness to cardiac cell fate specification. Genes Dev 32:389-401
Szmulewitz, Russell Z; Peer, Cody J; Ibraheem, Abiola et al. (2018) Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer. J Clin Oncol 36:1389-1395
Maron, Steven B; Alpert, Lindsay; Kwak, Heewon A et al. (2018) Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma. Cancer Discov 8:696-713

Showing the most recent 10 out of 668 publications